|
KCMF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.241100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.582360E-04 |
| Normal-vs-Stage2 |
9.888000E-02 |
| Normal-vs-Stage3 |
1.216170E-01 |
| Normal-vs-Stage4 |
4.206100E-02 |
| Stage1-vs-Stage2 |
5.395400E-01 |
| Stage1-vs-Stage3 |
1.137580E-01 |
| Stage1-vs-Stage4 |
3.635200E-01 |
| Stage2-vs-Stage3 |
6.240000E-01 |
| Stage2-vs-Stage4 |
9.062000E-01 |
| Stage3-vs-Stage4 |
6.502000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.460050E-03 |
| Normal-vs-AfricanAmerican |
9.469700E-02 |
| Normal-vs-Asian |
7.612000E-02 |
| Caucasian-vs-AfricanAmerican |
9.293600E-01 |
| Caucasian-vs-Asian |
3.626200E-02 |
| AfricanAmerican-vs-Asian |
6.738300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.520200E-03 |
| Normal-vs-Female |
1.622450E-03 |
| Male-vs-Female |
5.875400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.179000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.019800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.036560E-03 |
| Normal-vs-Age(81-100Yrs) |
4.707600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.571600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.631000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.348600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.827600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.917200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.274020E-02 |
| Normal-vs-Grade 2 |
6.03649999999512E-05 |
| Normal-vs-Grade 3 |
7.232300E-02 |
| Normal-vs-Grade 4 |
3.199800E-02 |
| Grade 1-vs-Grade 2 |
8.250800E-01 |
| Grade 1-vs-Grade 3 |
2.933000E-01 |
| Grade 1-vs-Grade 4 |
6.507000E-01 |
| Grade 2-vs-Grade 3 |
2.077600E-02 |
| Grade 2-vs-Grade 4 |
5.544800E-01 |
| Grade 3-vs-Grade 4 |
3.066800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.98249999999933E-05 |
| Normal-vs-ccB subtype |
1.270190E-02 |
| ccA subtype-vs-ccB subtype |
3.191200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.643600E-03 |
| Normal-vs-N1 |
7.112000E-02 |
| N0-vs-N1 |
2.187000E-01 |
|
|
